Virtual Benefit Solutions INC
Virtual Benefit Solutions INC was paid $1.56M by Medicaid between Jul 2020 and Jun 2023, across 24 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 33% of everything it billed.
NEWARK, CA 94560
Next to other Audiologist providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 975 | $22K | |
| 2021 | 16,888 | $393K | |
| 2022 | 32,438 | $1.12M | |
| 2023 | 4,359 | $26K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 33% | 8,147 | 3,908 | $523K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 17% | 9,933 | 5,200 | $270K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 15% | 6,805 | 4,020 | $232K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14% | 7,831 | 4,002 | $221K |
| 87428 | 7.7% | 3,150 | 1,962 | $120K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.4% | 7,200 | 4,027 | $101K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.0% | 4,910 | 2,819 | $32K |
| 86328 | 1.5% | 961 | 598 | $24K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.0% | 714 | 537 | $16K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 162 | 133 | $8K |
| 99443 | <1% | 1,020 | 441 | $5K | |
| 92557 | <1% | 780 | 698 | $4K |
12 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 70 | $3K |
| 86769 | <1% | 88 | $2K | |
| 69210 | <1% | 1,213 | $2K | |
| 99442 | <1% | 950 | $578.77 | |
| 98968 | <1% | 103 | $424.65 | |
| 98967 | <1% | 109 | $399.21 | |
| 99072 | <1% | 342 | $285.00 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 12 | $113.20 |
| 92552 | <1% | 12 | $75.39 | |
| 99441 | <1% | 82 | $10.16 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 49 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.